D. Sutton

D. Sutton, G. Rock, B. Clark, 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Laboratory abnormalities in thrombotic thrombocytopenic purpura

J. Kelton, Rock, D. Sutton, 1998 .

Intravascular coagulation in abruptio placentae.

D. Sutton, F. Bachmann, R. Hauser, 1971, American journal of obstetrics and gynecology.

A pilot study to compare the use of the Excorim staphylococcal protein immunoadsorption system and IVIG in chronic inflammatory demyelinating polyneuropathy.

L. Zinman, V. Bril, D. Sutton, 2005, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Use of intravenous immune globulin in the ICU: a retrospective review of prescribing practices and patient outcomes

J. Callum, J. Meyer, D. Sutton, 2010, Transfusion medicine.

Plasma exchange in acute renal transplant rejection.

C. Cardella, D. Sutton, P. Blake, 1990, Progress in clinical and biological research.

Pathophysiology of endotoxin shock in the primate.

D. Sutton, P. Rao, D. Cavanagh, 1970, American journal of obstetrics and gynecology.

A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group.

D. Churchill, W. Clark, D. Cattran, 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Dexamethasone/ifosfamide/cisplatin/etoposide (DICE) as therapy for patients with advanced refractory non-Hodgkin's lymphoma: preliminary report of a phase II study.

E. Warner, F. Shepherd, P. Goss, 1991, Annals of Oncology.

Treatment of Thrombotic Thrombocytopenic Purpura Using Solvent Detergent Treated Plasma.

P. Leblond, G. Wells, D. Sutton, 2005 .

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura

D. Sutton, G. Rock, N. Buskard, 1996, British journal of haematology.

Effect of intensive plasma exchange on renal transplant rejection and serum cytotoxic antibody.

C. Cardella, D. Sutton, J. Falk, 1978, Transplantation proceedings.

Apheresis: man versus machine

D. Sutton, G. Rock, 1997, Transfusion.

Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin: A case report

M. Malkin, J. Dalmau, D. Sutton, 1996, Cancer.

Acute Tumor Lysis Syndrome Secondary to Hydroxyurea in Acute Myeloid Leukemia

D. Sutton, H. Al-Omar, D. Amato, 2003, The Annals of pharmacotherapy.

INTENSIVE PLASMA EXCHANGE AND RENAL-TRANSPLANT REJECTION

C. Cardella, D. Sutton, P. Uldall, 1977, The Lancet.

Intensive plasma exchange, complement dependent microcytotoxicity and renal transplant rejection.

C. Cardella, D. Sutton, J. Falk, 1977, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.

E. D. Campbell, W. H. Carter, M. A. Baker, 1994, Archives of internal medicine.

Sezary syndrome in a patient with hairy cell leukemia in remission

M. Crump, D. Sutton, D. Pantalony, 1991, Cancer.

Central nervous system toxicity of high-dose cytosine arabinoside.

J. Deck, M. A. Baker, D. Sutton, 1983, Medical and pediatric oncology.

Treatment of AIDS-related non-Hodgkin's lymphoma with a twelve week chemotherapy program.

E. Warner, F. Shepherd, J. Brandwein, 1992, Leukemia & lymphoma.

Plasma Exchange When Myeloma Presents as Acute Renal Failure

Amit X Garg, Brendan J Barrett, A. Garg, 2005, Annals of Internal Medicine.

Intermediate Dose Thalidomide (200 mg Daily) has Comparable Efficacy and Less Toxicity than Higher Doses in Relapsed Multiple Myeloma

D. Reece, D. Sutton, A. Stewart, 2003, Leukemia & lymphoma.

Immunotherapy for chronic myelogenous leukemia: survival not affected by treatment in the stable phase.

W. H. Carter, D. Sutton, R. Taub, 1984, Cancer research.

Intensive therapy and autotransplant for patients with an incomplete response to front-line therapy for lymphoma.

R. Tsang, S. Sutcliffe, M. Crump, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange

J. Freedman, D. Sutton, G. Rock, 1997, Journal of clinical apheresis.

Thrombotic thrombocytopenic purpura associated with the acquired immune deficiency syndrome.

E. Bow, A. Kumar, D. Sutton, 1992, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

A controlled trial evaluating intensive plasma exchange in renal transplant recipients.

C. Cardella, D. Sutton, P. Uldall, 1980, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

ADAMTS-13 may not predict disease or outcome in patients with Thrombotic Thrombocytopenic Purpura.

P. Leblond, J. Sontrop, W. Clark, 2013, Thrombosis research.

Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group.

J. Kelton, D. Sutton, G. Rock, 1998, British journal of haematology.

Plasma Exchange for Acute Renal Failure of Myeloma-Logical, Yet Ineffective: Plasma Exchange When Myeloma Presents as Acute Renal Failure. A Randomized, Controlled Trial. Ann Int Medicine 143: 777-784, 2005.

W. Clark, D. Sutton, M. Sternbach, 2006, Journal of the American Society of Nephrology : JASN.

Sequential, cycling maintenance therapy for post transplant multiple myeloma

D. Sutton, S. Nanji, C. Chen, 2006, Bone Marrow Transplantation.

Results of Therapy for Acute Myeloid Leukemia in First Relapse.

A. Keating, J. Brandwein, M. A. Baker, 1991, Leukemia & lymphoma.